{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:40:13Z","timestamp":1790685613904,"version":"4.1.0"},"reference-count":17,"publisher":"European Centre for Disease Control and Prevention (ECDC)","issue":"46","license":[{"start":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T00:00:00Z","timestamp":1573689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11,14]]},"abstract":"<jats:p>Investments to reduce the spread of antimicrobial resistance (AMR) in the European Union have been made, including efforts to strengthen prudent antimicrobial use. Using segmented regression, we report decreasing and stabilising trends in data reported to the European Surveillance of Antimicrobial Consumption Network and stabilising trends in data reported to the European Antimicrobial Resistance Surveillance Network. Our results could be an early indication of the effect of prioritising AMR on the public health agenda.<\/jats:p>","DOI":"10.2807\/1560-7917.es.2019.24.46.1900656","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T15:55:13Z","timestamp":1573746913000},"update-policy":"https:\/\/doi.org\/10.2807\/1560-7917.es.crp2020","source":"Crossref","is-referenced-by-count":24,"title":["Decreasing and stabilising trends of antimicrobial consumption and resistance in Escherichia coli and Klebsiella pneumoniae in segmented regression analysis, European Union\/European Economic Area, 2001 to 2018"],"prefix":"10.2807","volume":"24","author":[{"given":"Germ\u00e1n","family":"Pe\u00f1alva","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocio, CSIC, University of Seville, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liselotte Diaz","family":"H\u00f6gberg","sequence":"additional","affiliation":[{"name":"European Centre for Disease Prevention and Control, Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Weist","sequence":"additional","affiliation":[{"name":"European Centre for Disease Prevention and Control, Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Vlahovi\u0107-Pal\u010devski","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, University Hospital Rijeka \/ Medical Faculty and Faculty of Health Studies, University of Rijeka, Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1425-3220","authenticated-orcid":false,"given":"Ole","family":"Heuer","sequence":"additional","affiliation":[{"name":"European Centre for Disease Prevention and Control, Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique L","family":"Monnet","sequence":"additional","affiliation":[{"name":"European Centre for Disease Prevention and Control, Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ESAC-Net study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"EARS-Net study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7995","reference":[{"issue":"1","key":"r1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","article-title":"Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis.","volume":"19","author":"Cassini","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"41","key":"r2","doi-asserted-by":"crossref","first-page":"20928","DOI":"10.2807\/1560-7917.ES2014.19.41.20928","article-title":"European Antibiotic Awareness Day: a five-year perspective of Europe-wide actions to promote prudent use of antibiotics.","volume":"19","author":"Earnshaw","year":"2014","journal-title":"Euro Surveill"},{"key":"r3","unstructured":"European Commission (EC). Directorate-General for Health and Consumers. Communication from the Commission to the European Parliament and the Council. Action plan against the rising threats from antimicrobial resistance. Brussels: EC; 2011. Available from: https:\/\/ec.europa.eu\/health\/amr\/sites\/amr\/files\/communication_amr_2011_748_en.pdf"},{"key":"r4","unstructured":"World Health Organization (WHO). Global Action Plan on Antimicrobial Resistance. Geneva: WHO; 2015. Available from: https:\/\/www.who.int\/antimicrobial-resistance\/publications\/global-action-plan\/en\/"},{"key":"r5","unstructured":"European Commission (EC). Commission Notice of 1 July 2017 on EU Guidelines for the prudent use of antimicrobials in human health. Official Journal of the European Union. Luxembourg: Publications Office of the European Union. 1.7.2017:C 212. Available from:https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF\/?uri=CELEX:52017XC0701(01)&from=EN"},{"key":"r6","unstructured":"European Commission (EC). A European One Health Action Plan against Antimicrobial Resistance (AMR). Brussels: EC; 2017. Available from: https:\/\/ec.europa.eu\/health\/amr\/sites\/amr\/files\/amr_action_plan_2017_en.pdf"},{"key":"r7","unstructured":"Council of the European Union. Council Conclusions on the next steps towards making the EU a best practice region in combatting antimicrobial resistance. Luxembourg: Publications Office of the European Union. 25.6.2019:C 214. Available from: https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF\/?uri=CELEX:52019XG0625(01)&from=EN"},{"key":"r8","unstructured":"World Health Organization (WHO). Collaborating Centre for Drug Statistics Methodology. ATC Index with DDDs. Geneva: WHO; 2019: Available from https:\/\/www.whocc.no\/atc_ddd_index\/"},{"issue":"10","key":"r9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001104","article-title":"Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe.","volume":"8","author":"de Kraker","year":"2011","journal-title":"PLoS Med"},{"issue":"1","key":"r10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/2047-2994-2-6","article-title":"The rise of carbapenem resistance in Europe: just the tip of the iceberg?","volume":"2","author":"Magiorakos","year":"2013","journal-title":"Antimicrob Resist Infect Control"},{"issue":"9","key":"r11","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2019.24.9.1900123","article-title":"Worsening epidemiological situation of carbapenemase-producing Enterobacteriaceae in Europe, assessment by national experts from 37 countries, July 2018.","volume":"24","author":"Brolund","year":"2019","journal-title":"Euro Surveill"},{"key":"r12","unstructured":"European Centre for Disease Prevention and Control (ECDC). Surveillance Atlas of Infectious Diseases. Stockholm: ECDC; 2018. Available from: http:\/\/atlas.ecdc. europa.eu."},{"issue":"3","key":"r13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates.","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"issue":"2","key":"r14","doi-asserted-by":"crossref","first-page":"21008","DOI":"10.2807\/1560-7917.ES2015.20.2.21008","article-title":"Widespread implementation of EUCAST breakpoints for antibacterial susceptibility testing in Europe.","volume":"20","author":"Brown","year":"2015","journal-title":"Euro Surveill"},{"issue":"9","key":"r15","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/1469-0691.12028","article-title":"The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System.","volume":"19","author":"de Kraker","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"r16","unstructured":"European Centre for Disease Prevention and Control (ECDC). Surveillance of antimicrobial resistance in Europe 2017. Stockholm: ECDC; 2018. Available from: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/EARS-Net-report-2017-update-jan-2019.pdf"},{"issue":"3","key":"r17","first-page":"278","article-title":"Antibiotics obtained without a prescription in Europe.","volume":"8","author":"Safrany","year":"2002","journal-title":"Lancet Infect Dis"}],"container-title":["Eurosurveillance"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T10:16:38Z","timestamp":1674296198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurosurveillance.org\/content\/10.2807\/1560-7917.ES.2019.24.46.1900656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,14]]},"references-count":17,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2019,11,14]]}},"URL":"https:\/\/doi.org\/10.2807\/1560-7917.es.2019.24.46.1900656","relation":{},"ISSN":["1560-7917"],"issn-type":[{"value":"1560-7917","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11,14]]}}}